BIORESTORATIVE THERAPIES, INC. (BRTX) Gross Margin
- Gross margin · 12 months: Value 92.09%; Formula and calculation Gross profit / revenue. Period ending 2026-03-31..
Gross margin
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 92.09% | Gross profit / revenue. Period ending 2026-03-31. $329.55K ÷ $357.87K × 100 ≈ 92.09% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 329.55K USD | Gross Profit |
| Revenue | 357.87K USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 28.32K USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-03-31 | $329.55K | $357.87K | $28.32K | 92.09% |
| 2025-12-31 | $335.86K | $359.70K | $23.84K | 93.37% |
| 2025-09-30 | $357.85K | $383.40K | $25.55K | 93.34% |
| 2025-06-30 | $571.98K | $605.20K | $33.22K | 94.51% |
| 2025-03-31 | $360.02K | $391.00K | $30.98K | 92.08% |
| 2024-12-31 | $372.93K | $401.00K | $28.07K | 93.00% |
| 2024-09-30 | (m) | $377.00K | (m) | (m) |
| 2024-06-30 | (m) | $174.10K | (m) | (m) |
| 2024-03-31 | (m) | $149.50K | (m) | (m) |
| 2023-12-31 | (m) | $145.80K | (m) | (m) |
| 2023-09-30 | (m) | $130.20K | (m) | (m) |
| 2023-06-30 | (m) | $128.50K | (m) | (m) |
| 2023-03-31 | (m) | $135.10K | (m) | (m) |
| 2022-12-31 | (m) | $119.80K | (m) | (m) |
| 2022-09-30 | (m) | $121.10K | (m) | (m) |
| 2022-06-30 | (m) | $100.10K | (m) | (m) |
| 2022-03-31 | (m) | $44.00K | (m) | (m) |
| 2021-12-31 | (m) | $46.00K | (m) | (m) |
| 2021-09-30 | (m) | $58.00K | (m) | (m) |
| 2021-06-30 | (m) | $65.00K | (m) | (m) |
| 2021-03-31 | (m) | $69.00K | (m) | (m) |
| 2020-12-31 | (m) | $77.00K | (m) | (m) |
| 2020-09-30 | (m) | $92.00K | (m) | (m) |
| 2020-06-30 | (m) | $115.00K | (m) | (m) |
| 2020-03-31 | (m) | $127.00K | (m) | (m) |
| 2019-12-31 | (m) | $130.00K | (m) | (m) |
| 2019-09-30 | (m) | $127.00K | (m) | (m) |
| 2019-06-30 | (m) | $115.00K | (m) | (m) |
| 2019-03-31 | (m) | $121.00K | (m) | (m) |
| 2018-12-31 | (m) | $111.00K | (m) | (m) |
| 2018-09-30 | (m) | $120.00K | (m) | (m) |
| 2018-06-30 | (m) | $110.00K | (m) | (m) |
| 2018-03-31 | (m) | $93.00K | (m) | (m) |
| 2017-12-31 | $81.00K | $81.00K | (m) | 100.00% |
| 2017-09-30 | $49.05K | $49.08K | (m) | 99.96% |
| 2017-06-30 | $38.05K | $38.08K | (m) | 99.94% |
| 2017-03-31 | $34.14K | $34.23K | (m) | 99.73% |
| 2016-12-31 | $36.25K | $36.35K | (m) | 99.72% |
| 2016-09-30 | $169.82K | $229.41K | (m) | 74.03% |
| 2016-06-30 | $210.02K | $320.53K | (m) | 65.52% |
| 2016-03-31 | $268.06K | $453.14K | (m) | 59.16% |
| 2015-12-31 | $367.41K | $628.91K | (m) | 58.42% |
| 2015-09-30 | $202.25K | $509.54K | (m) | 39.69% |
| 2015-06-30 | $250.86K | $573.35K | (m) | 43.75% |
| 2015-03-31 | $310.32K | $600.52K | (m) | 51.67% |
| 2014-12-31 | $202.16K | $416.00K | (m) | 48.60% |
| 2014-09-30 | $227.71K | $336.25K | (m) | 67.72% |
| 2014-06-30 | $134.00K | $176.44K | (m) | 75.95% |
| 2014-03-31 | $819.00 | $925.00 | (m) | 88.54% |
| 2013-12-31 | $1.47K | $1.68K | (m) | 87.62% |
| 2013-09-30 | $1.80K | $2.04K | (m) | 88.01% |
| 2013-06-30 | $5.64K | $7.14K | (m) | 78.93% |
| 2013-03-31 | $15.25K | $16.72K | (m) | 91.21% |
| 2012-12-31 | $14.28K | $15.59K | (m) | 91.62% |
| 2012-09-30 | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) |
| 2011-12-31 | $0.00 | $0.00 | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |